Email ID
Password
Scrip   
Eisai takes up option to acquire AkaRx
21 December 2009
Ian Haydock

Eisai is to acquire AkaRx for $255 million, exercising an option to buy the private US firm it obtained as part of the 2008 purchase of MGI Pharma.

The deal will be routed through Eisai's US subsidiary, of which New Jersey-based AkaRx will become a wholly owned subsidiary, and...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36